WEST PALM BEACH, Fla. - A Florida federal judge overseeing the Trasylol multidistrict litigation on March 22 granted summary judgment after finding that a nephrologist's testimony failed to show that the drug caused transient changes in the plaintiff's kidneys or increased his risk of death (In Re: Trasylol Products Liability Litigation, MDL Docket No. 1928, No. 08-md-1928, David Quinones, et al. v. Bayer Corporation, et al., No. 09-80682, S.D. Fla.)....(read more)![]()
↧